Table: Chiome Bioscience - Q1 parent results
May 11 (Reuters)-
Chiome Bioscience Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2023 Mar 31, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 169 mln 128 mln
(+31.8 pct) (-47.8 pct)
Operating loss 225 mln loss 486 mln
Recurring loss 227 mln loss 491 mln
Net loss 227 mln loss 492 mln
EPS loss 4.70 yen loss 11.66 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Chiome Bioscience Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4583.T